While some Depo-Provera side effects fade quickly, others can persist. This article focuses on lingering or late-appearing side effects, how they are documented in medical records, and when they might support a legal claim.
Depo-Provera, an injectable contraceptive medication, has been used by millions of women worldwide since its approval by the FDA in 1992. While the medication is effective for birth control, emerging research has raised concerns about potential long-term health risks, particularly related to brain tumor development.
Understanding the potential long-term side effects of Depo-Provera can help you make informed decisions about your health and legal options. This article explores what current research shows about extended use of the medication and what it may mean for women who have used it for many years.
Understanding Long-Term Depo-Provera Use
Depo-Provera is administered as an injection every three months to prevent pregnancy. Many women have used the medication for extended periods, sometimes for years or even decades. The cumulative exposure from repeated injections over many years may be a factor in the increased health risks observed in long-term users.
According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Each injection releases the hormone medroxyprogesterone acetate slowly over time, maintaining contraceptive effectiveness for approximately 12 to 14 weeks. When used over many years, this cumulative hormone exposure may contribute to various health effects, including potential risks related to brain tumor development.
Potential Long-Term Side Effects
Research has identified several potential long-term side effects associated with Depo-Provera use, particularly in women who used the medication for extended periods:
Women who developed meningiomas after Depo-Provera injections may qualify for compensation.
No-cost evaluation for women who used Depo-Provera and developed a brain tumor.
Check your Depo-Provera eligibilityBrain Tumor Risk: Recent research has identified a potential link between long-term Depo-Provera use and the development of meningiomas, which are brain tumors that form in the protective membranes surrounding the brain and spinal cord. The risk appears to be higher in women who used the medication for longer durations.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
Bone Density: Some research has suggested that Depo-Provera use may be associated with decreased bone density, particularly with long-term use. This may be a concern for women who used the medication for many years.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Weight Changes: Some women may experience weight changes while using Depo-Provera, and these changes may persist or develop over time with extended use.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Menstrual Changes: Depo-Provera typically causes changes in menstrual patterns, and these changes may persist after stopping the medication, particularly with long-term use.
A confidential case review can help you understand your Depo-Provera legal options.
No obligation. Understand your Depo-Provera legal options at no cost.
Request a free Depo-Provera evaluationAccording to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Mood Changes: Some women may experience mood changes while using Depo-Provera, and these changes may be more pronounced with extended use.
It's important to note that not all women who use Depo-Provera will experience these side effects, and individual experiences may vary. However, understanding these potential risks can help you make informed decisions about your health.
The Connection Between Depo-Provera and Meningiomas
One of the most significant long-term side effects that has emerged in recent research is the potential connection between Depo-Provera and meningioma development. Scientific research has identified a potential link between progestogen-containing medications like Depo-Provera and the development of these brain tumors.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
Don't wait on your Depo-Provera claim—statutes of limitations may apply.
Get a free Depo-Provera case review and learn whether you may qualify.
See if you qualify for a Depo-Provera lawsuitAccording to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Studies have found that women who used progestogen-based contraceptives, including Depo-Provera, for extended periods may have an increased risk of developing meningiomas. The risk appears to be higher in women who used the medication for longer durations, suggesting a dose-response relationship.
The mechanism by which progestogens may contribute to meningioma development is not fully understood, but research suggests that these hormones may stimulate the growth of meningioma cells. Meningiomas have been found to have receptors for progestogen hormones, which may explain why exposure to these hormones could promote tumor growth.
Factors That May Influence Long-Term Risks
Several factors may influence the long-term risks associated with Depo-Provera use:
According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Duration of Use: Women who used Depo-Provera for extended periods, particularly five years or more, may have a higher risk of certain side effects, including potential brain tumor development.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
If you used Depo-Provera and were diagnosed with a brain tumor, you may have legal options.
Free, confidential Depo-Provera case review. Find out if you qualify.
Get a free Depo-Provera case reviewAccording to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Age at First Use: The age at which you first started using Depo-Provera may influence your risk profile, though research in this area continues to evolve.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Individual Health Factors: Other health conditions and factors may influence your individual risk of developing side effects.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
Genetic Factors: Some individuals may have genetic factors that influence their risk of developing certain side effects.
Concurrent Medications: Other medications you may be taking could interact with Depo-Provera and influence your risk profile.
It's important to discuss your individual risk factors with your healthcare provider, who can help you understand your specific situation and recommend appropriate monitoring or screening.
Women who developed meningiomas after Depo-Provera injections may qualify for compensation.
No-cost evaluation for women who used Depo-Provera and developed a brain tumor.
Check your Depo-Provera eligibilityMonitoring and Screening Recommendations
If you've used Depo-Provera for extended periods, your healthcare provider may recommend appropriate monitoring or screening. These recommendations may include:
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Regular Health Checkups: Regular checkups can help monitor for potential side effects and address any concerns that may arise.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Bone Density Testing: If you've used Depo-Provera for extended periods, your healthcare provider may recommend bone density testing to monitor for potential bone density changes.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
A confidential case review can help you understand your Depo-Provera legal options.
No obligation. Understand your Depo-Provera legal options at no cost.
Request a free Depo-Provera evaluationAccording to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Imaging Studies: If you're experiencing symptoms that could be related to brain tumors, your healthcare provider may recommend imaging studies such as MRI or CT scans.
Symptom Monitoring: Being aware of potential symptoms and reporting them to your healthcare provider can help ensure timely evaluation and treatment if needed.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
Discussion of Risks: Having open discussions with your healthcare provider about potential risks and how to monitor for them can help you make informed decisions about your health.
What to Do If You're Experiencing Side Effects
If you've used Depo-Provera for extended periods and are experiencing side effects, there are several steps you can take:
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
Don't wait on your Depo-Provera claim—statutes of limitations may apply.
Get a free Depo-Provera case review and learn whether you may qualify.
See if you qualify for a Depo-Provera lawsuitTalk to Your Healthcare Provider: Discuss your concerns with your healthcare provider, who can help evaluate your symptoms and recommend appropriate treatment or monitoring.
Document Your Symptoms: Keeping a record of your symptoms, when they started, and how they've changed over time can help your healthcare provider evaluate your situation.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
Consider Your Legal Options: If you've used Depo-Provera for an extended period and have been diagnosed with a meningioma or other serious side effect, you may want to learn about your legal options. A free case review can help determine whether you may qualify for a lawsuit.
Stay Informed: Research in this area continues to evolve. Stay informed about new developments and discuss them with your healthcare provider.
Legal Considerations for Long-Term Side Effects
If you've used Depo-Provera for extended periods and experienced serious side effects, particularly a meningioma diagnosis, you may have legal options. Litigation related to Depo-Provera and long-term side effects is developing as more women learn about the potential connection between their medication use and health problems.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
If you used Depo-Provera and were diagnosed with a brain tumor, you may have legal options.
Free, confidential Depo-Provera case review. Find out if you qualify.
Get a free Depo-Provera case reviewCases are being filed alleging that manufacturers knew about the risks but failed to adequately warn patients and healthcare providers. If you've used Depo-Provera for an extended period and developed serious side effects, you may be entitled to compensation for medical expenses, lost wages, pain and suffering, future medical care, and reduced quality of life.
According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
A free case review can help you understand your potential rights and options. This initial evaluation is confidential and does not create any obligation on your part. If you're ready to begin, you can contact us for a free case review.
Important Considerations
Understanding the long-term side effects of Depo-Provera requires recognizing several important points:
Research Continues to Evolve: Scientific research in this area continues to develop, and new findings may emerge that change our understanding of long-term risks.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
Individual Experiences Vary: Not all women who use Depo-Provera will experience long-term side effects, and individual experiences may vary significantly.
Women who developed meningiomas after Depo-Provera injections may qualify for compensation.
No-cost evaluation for women who used Depo-Provera and developed a brain tumor.
Check your Depo-Provera eligibilityA 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
Multiple Factors May Be Involved: The relationship between Depo-Provera use and long-term side effects is complex and may involve multiple factors beyond medication use.
Medical Monitoring May Be Appropriate: If you've used Depo-Provera for extended periods, your healthcare provider may recommend appropriate monitoring or screening.
The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
Legal Options May Be Available: If you've experienced serious long-term side effects after using Depo-Provera, you may have legal options. A free case review can help determine whether you may qualify.
See if you qualify for a free case review to learn more about your potential rights and options. You can also learn more about Depo-Provera lawsuit information and your potential rights.
Frequently Asked Questions
- Q: What are the most serious long-term side effects of Depo-Provera?
- According to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
A confidential case review can help you understand your Depo-Provera legal options.
No obligation. Understand your Depo-Provera legal options at no cost.
Request a free Depo-Provera evaluationAccording to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Recent research has identified a potential link between long-term Depo-Provera use and the development of meningiomas, which are brain tumors. Other potential long-term side effects may include bone density changes and persistent menstrual changes.
- Q: How long do you have to use Depo-Provera to be at risk for long-term side effects?
- The risk of certain side effects, including potential brain tumor development, appears to increase with longer duration of use. Women who used Depo-Provera for five years or more may have a higher risk.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
- Q: Can long-term side effects develop after stopping Depo-Provera?
- The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.
Some side effects may persist or develop after stopping Depo-Provera, particularly if you used the medication for extended periods. If you're concerned, discuss your situation with your healthcare provider.
A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.
Don't wait on your Depo-Provera claim—statutes of limitations may apply.
Get a free Depo-Provera case review and learn whether you may qualify.
See if you qualify for a Depo-Provera lawsuit- Q: What should I do if I'm experiencing long-term side effects?
- If you're experiencing side effects, discuss your concerns with your healthcare provider, who can help evaluate your symptoms and recommend appropriate treatment or monitoring.
- Q: Do I have legal options if I've experienced long-term side effects?
- If you've used Depo-Provera for an extended period and experienced serious side effects, particularly a meningioma diagnosis, you may have legal options. A free case review can help determine whether you may qualify for a lawsuit.
- Q: How do I know if my side effects are related to Depo-Provera?
- According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.
Determining whether side effects are related to Depo-Provera can be complex and may require medical evaluation. If you're concerned, discuss your situation with your healthcare provider and consider a free case review to learn about your legal options.
Important Disclaimers
Understanding the long-term side effects of Depo-Provera is important for women who have used the medication. If you've used Depo-Provera for an extended period and have experienced serious side effects, understanding your legal rights and options is important.
If you used Depo-Provera and were diagnosed with a brain tumor, you may have legal options.
Free, confidential Depo-Provera case review. Find out if you qualify.
Get a free Depo-Provera case reviewAccording to FDA approval history, Depo-Provera (medroxyprogesterone acetate injectable suspension) has been marketed in the United States since 1992, with labeling updated multiple times as progestin safety data evolved.
You do not have to navigate insurer letters or court deadlines alone. Our network offers free case reviews to connect you with independent firms that handle these matters regularly.
Top Tier Legal, LLC is not a law firm and does not provide legal advice. This content is for informational purposes only. Submitting information does not create an attorney-client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm. Past results do not guarantee future outcomes.
